4//SEC Filing
Stanton Marshall S. 4
Accession 0001849615-25-000003
CIK 0000784199other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 6:08 PM ET
Size
8.5 KB
Accession
0001849615-25-000003
Insider Transaction Report
Form 4
ARTIVION, INC.AORT
Stanton Marshall S.
SVP, Clinical & MD Affair
Transactions
- Exercise/Conversion
Common Stock
2025-08-27$11.03/sh+18,200$200,746→ 82,400 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-27−18,200→ 0 totalExercise: $11.03From: 2023-11-08Exp: 2029-11-08→ Common Stock (18,200 underlying) - Sale
Common Stock
2025-08-27$44.02/sh−18,200$801,219→ 64,200 total
Footnotes (2)
- [F1]Reflects weighted average price. Range of prices were between $43.84 to $44.26. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.
Documents
Issuer
ARTIVION, INC.
CIK 0000784199
Entity typeother
Related Parties
1- filerCIK 0001849615
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 6:08 PM ET
- Size
- 8.5 KB